WO2006061600A1 - Particules destinees a servir de supports solides, et leur procede de preparation - Google Patents
Particules destinees a servir de supports solides, et leur procede de preparation Download PDFInfo
- Publication number
- WO2006061600A1 WO2006061600A1 PCT/GB2005/004681 GB2005004681W WO2006061600A1 WO 2006061600 A1 WO2006061600 A1 WO 2006061600A1 GB 2005004681 W GB2005004681 W GB 2005004681W WO 2006061600 A1 WO2006061600 A1 WO 2006061600A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- particle
- particles
- diffraction pattern
- process according
- identifier
- Prior art date
Links
- 239000002245 particle Substances 0.000 title claims abstract description 295
- 238000000034 method Methods 0.000 title claims abstract description 110
- 230000008569 process Effects 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 239000007787 solid Substances 0.000 title claims abstract description 22
- 229910052751 metal Inorganic materials 0.000 claims abstract description 27
- 239000002184 metal Substances 0.000 claims abstract description 27
- 238000006243 chemical reaction Methods 0.000 claims abstract description 24
- 239000000463 material Substances 0.000 claims description 162
- 239000000758 substrate Substances 0.000 claims description 51
- 230000005855 radiation Effects 0.000 claims description 42
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 31
- 150000001413 amino acids Chemical class 0.000 claims description 26
- 150000001875 compounds Chemical class 0.000 claims description 22
- 108091034117 Oligonucleotide Proteins 0.000 claims description 21
- 150000005829 chemical entities Chemical class 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 21
- 239000000126 substance Substances 0.000 claims description 21
- 125000005647 linker group Chemical group 0.000 claims description 20
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 150000001412 amines Chemical class 0.000 claims description 13
- 239000011248 coating agent Substances 0.000 claims description 13
- 238000000576 coating method Methods 0.000 claims description 13
- 125000000524 functional group Chemical group 0.000 claims description 13
- 108020004707 nucleic acids Proteins 0.000 claims description 12
- 102000039446 nucleic acids Human genes 0.000 claims description 12
- 150000007523 nucleic acids Chemical class 0.000 claims description 12
- 229910052710 silicon Inorganic materials 0.000 claims description 12
- 239000010703 silicon Substances 0.000 claims description 12
- 239000004411 aluminium Substances 0.000 claims description 10
- 229910052782 aluminium Inorganic materials 0.000 claims description 10
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 10
- 150000002739 metals Chemical class 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 7
- VUCNQOPCYRJCGQ-UHFFFAOYSA-N 2-[4-(hydroxymethyl)phenoxy]acetic acid Chemical compound OCC1=CC=C(OCC(O)=O)C=C1 VUCNQOPCYRJCGQ-UHFFFAOYSA-N 0.000 claims description 6
- 206010073306 Exposure to radiation Diseases 0.000 claims description 6
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 4
- 150000003384 small molecules Chemical class 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 239000012530 fluid Substances 0.000 claims description 3
- 239000000178 monomer Substances 0.000 claims description 3
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- 108010038807 Oligopeptides Proteins 0.000 claims description 2
- 102000015636 Oligopeptides Human genes 0.000 claims description 2
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 2
- 229960002684 aminocaproic acid Drugs 0.000 claims description 2
- 125000003700 epoxy group Chemical group 0.000 claims description 2
- 239000003446 ligand Substances 0.000 claims description 2
- 229920000570 polyether Polymers 0.000 claims description 2
- 102000004856 Lectins Human genes 0.000 claims 1
- 108090001090 Lectins Proteins 0.000 claims 1
- 239000002523 lectin Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 238000003541 multi-stage reaction Methods 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 72
- -1 for example Chemical class 0.000 description 41
- 125000006239 protecting group Chemical group 0.000 description 30
- 235000001014 amino acid Nutrition 0.000 description 25
- 238000003786 synthesis reaction Methods 0.000 description 19
- 230000015572 biosynthetic process Effects 0.000 description 18
- 238000004519 manufacturing process Methods 0.000 description 16
- 230000003287 optical effect Effects 0.000 description 15
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 11
- 238000011161 development Methods 0.000 description 11
- 235000012431 wafers Nutrition 0.000 description 11
- 125000003277 amino group Chemical group 0.000 description 10
- 238000005859 coupling reaction Methods 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 9
- 230000008878 coupling Effects 0.000 description 9
- 238000010168 coupling process Methods 0.000 description 9
- 238000004049 embossing Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 239000011295 pitch Substances 0.000 description 8
- 102000004196 processed proteins & peptides Human genes 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 239000002777 nucleoside Substances 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 6
- 125000000539 amino acid group Chemical group 0.000 description 6
- 238000010511 deprotection reaction Methods 0.000 description 6
- 239000002773 nucleotide Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 238000010532 solid phase synthesis reaction Methods 0.000 description 6
- JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000005530 etching Methods 0.000 description 5
- 239000011521 glass Substances 0.000 description 5
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 5
- 150000003833 nucleoside derivatives Chemical class 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- 238000001069 Raman spectroscopy Methods 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 239000011651 chromium Substances 0.000 description 4
- 229910052804 chromium Inorganic materials 0.000 description 4
- 230000000295 complement effect Effects 0.000 description 4
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000010894 electron beam technology Methods 0.000 description 4
- 239000010408 film Substances 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 238000011065 in-situ storage Methods 0.000 description 4
- 238000010647 peptide synthesis reaction Methods 0.000 description 4
- 238000000206 photolithography Methods 0.000 description 4
- 229920002120 photoresistant polymer Polymers 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 4
- 238000012163 sequencing technique Methods 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000004528 spin coating Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- WGTYBPLFGIVFAS-UHFFFAOYSA-M tetramethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)C WGTYBPLFGIVFAS-UHFFFAOYSA-M 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 description 3
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical group O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 230000006820 DNA synthesis Effects 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000012317 TBTU Substances 0.000 description 3
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 239000000956 alloy Substances 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 238000000609 electron-beam lithography Methods 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 238000005755 formation reaction Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 238000000608 laser ablation Methods 0.000 description 3
- 238000001459 lithography Methods 0.000 description 3
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000007017 scission Effects 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- 150000003573 thiols Chemical class 0.000 description 3
- VGIRNWJSIRVFRT-UHFFFAOYSA-N 2',7'-difluorofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(F)C(=O)C=C2OC2=CC(O)=C(F)C=C21 VGIRNWJSIRVFRT-UHFFFAOYSA-N 0.000 description 2
- FPCPONSZWYDXRD-UHFFFAOYSA-N 6-(9h-fluoren-9-ylmethoxycarbonylamino)hexanoic acid Chemical compound C1=CC=C2C(COC(=O)NCCCCCC(=O)O)C3=CC=CC=C3C2=C1 FPCPONSZWYDXRD-UHFFFAOYSA-N 0.000 description 2
- 239000012099 Alexa Fluor family Substances 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical group N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 108010010369 HIV Protease Proteins 0.000 description 2
- XNSAINXGIQZQOO-UHFFFAOYSA-N L-pyroglutamyl-L-histidyl-L-proline amide Natural products NC(=O)C1CCCN1C(=O)C(NC(=O)C1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 102400000243 Leu-enkephalin Human genes 0.000 description 2
- 108010022337 Leucine Enkephalin Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 102400000160 Thymopentin Human genes 0.000 description 2
- 101800001703 Thymopentin Proteins 0.000 description 2
- 239000000627 Thyrotropin-Releasing Hormone Substances 0.000 description 2
- 102400000336 Thyrotropin-releasing hormone Human genes 0.000 description 2
- 101800004623 Thyrotropin-releasing hormone Proteins 0.000 description 2
- 108010004977 Vasopressins Proteins 0.000 description 2
- 102000002852 Vasopressins Human genes 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 125000005076 adamantyloxycarbonyl group Chemical group C12(CC3CC(CC(C1)C3)C2)OC(=O)* 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000012062 aqueous buffer Substances 0.000 description 2
- KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 2
- 125000004429 atom Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000003636 chemical group Chemical group 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- 239000013626 chemical specie Substances 0.000 description 2
- 238000011960 computer-aided design Methods 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229960000956 coumarin Drugs 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclopentanone Chemical compound O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 238000000708 deep reactive-ion etching Methods 0.000 description 2
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 2
- 125000005442 diisocyanate group Chemical group 0.000 description 2
- 239000003596 drug target Substances 0.000 description 2
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
- 239000003822 epoxy resin Substances 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- URLZCHNOLZSCCA-UHFFFAOYSA-N leu-enkephalin Chemical group C=1C=C(O)C=CC=1CC(N)C(=O)NCC(=O)NCC(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 URLZCHNOLZSCCA-UHFFFAOYSA-N 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000001127 nanoimprint lithography Methods 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- SJYNFBVQFBRSIB-UHFFFAOYSA-N norbornadiene Chemical compound C1=CC2C=CC1C2 SJYNFBVQFBRSIB-UHFFFAOYSA-N 0.000 description 2
- 238000002515 oligonucleotide synthesis Methods 0.000 description 2
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 238000000059 patterning Methods 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 229920000647 polyepoxide Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000002310 reflectometry Methods 0.000 description 2
- 239000003488 releasing hormone Substances 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 238000010583 slow cooling Methods 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000004544 sputter deposition Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- WGTODYJZXSJIAG-UHFFFAOYSA-N tetramethylrhodamine chloride Chemical compound [Cl-].C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C(O)=O WGTODYJZXSJIAG-UHFFFAOYSA-N 0.000 description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
- PSWFFKRAVBDQEG-YGQNSOCVSA-N thymopentin Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PSWFFKRAVBDQEG-YGQNSOCVSA-N 0.000 description 2
- 229960004517 thymopentin Drugs 0.000 description 2
- 229940034199 thyrotropin-releasing hormone Drugs 0.000 description 2
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 2
- BJFIDCADFRDPIO-DZCXQCEKSA-N (2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloeicos-4-yl]-oxomethyl]-2-pyrrolidinecarboxamide Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1 BJFIDCADFRDPIO-DZCXQCEKSA-N 0.000 description 1
- CBPJQFCAFFNICX-IBGZPJMESA-N (2s)-2-(9h-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoic acid Chemical compound C1=CC=C2C(COC(=O)N[C@@H](CC(C)C)C(O)=O)C3=CC=CC=C3C2=C1 CBPJQFCAFFNICX-IBGZPJMESA-N 0.000 description 1
- DEQANNDTNATYII-OULOTJBUSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-19-[[(2r)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-n-[(2r,3r)-1,3-dihydroxybutan-2-yl]-7-[(1r)-1-hydroxyethyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxa Chemical compound C([C@@H](N)C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC1=O)C(=O)N[C@H](CO)[C@H](O)C)C1=CC=CC=C1 DEQANNDTNATYII-OULOTJBUSA-N 0.000 description 1
- PUDHBTGHUJUUFI-SCTWWAJVSA-N (4r,7s,10s,13r,16s,19r)-10-(4-aminobutyl)-n-[(2s,3r)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2r)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-p Chemical compound C([C@H]1C(=O)N[C@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H](CSSC[C@@H](C(=O)N1)NC(=O)[C@H](N)CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O)=O)C(C)C)C1=CC=C(O)C=C1 PUDHBTGHUJUUFI-SCTWWAJVSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- JVVRCYWZTJLJSG-UHFFFAOYSA-N 4-dimethylaminophenol Chemical compound CN(C)C1=CC=C(O)C=C1 JVVRCYWZTJLJSG-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-dimethylaminopyridine Substances CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
- 239000000275 Adrenocorticotropic Hormone Substances 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- IISBACLAFKSPIT-UHFFFAOYSA-N Bisphenol A Natural products C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 description 1
- 108010037003 Buserelin Proteins 0.000 description 1
- 102400000739 Corticotropin Human genes 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 1
- 108010036949 Cyclosporine Proteins 0.000 description 1
- 108010000437 Deamino Arginine Vasopressin Proteins 0.000 description 1
- GJKXGJCSJWBJEZ-XRSSZCMZSA-N Deslorelin Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CNC2=CC=CC=C12 GJKXGJCSJWBJEZ-XRSSZCMZSA-N 0.000 description 1
- 108010092674 Enkephalins Proteins 0.000 description 1
- 108010056764 Eptifibatide Proteins 0.000 description 1
- 108010045937 Felypressin Proteins 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 108700012941 GNRH1 Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 1
- 108010069236 Goserelin Proteins 0.000 description 1
- BLCLNMBMMGCOAS-URPVMXJPSA-N Goserelin Chemical compound C([C@@H](C(=O)N[C@H](COC(C)(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NNC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 BLCLNMBMMGCOAS-URPVMXJPSA-N 0.000 description 1
- 239000000095 Growth Hormone-Releasing Hormone Substances 0.000 description 1
- 101001135995 Homo sapiens Probable peptidyl-tRNA hydrolase Proteins 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 description 1
- 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108010000817 Leuprolide Proteins 0.000 description 1
- 108010048179 Lypressin Proteins 0.000 description 1
- 229920001367 Merrifield resin Polymers 0.000 description 1
- 108010021717 Nafarelin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108010016076 Octreotide Proteins 0.000 description 1
- 101800000989 Oxytocin Proteins 0.000 description 1
- 102400000050 Oxytocin Human genes 0.000 description 1
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010067902 Peptide Library Proteins 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical class OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 108010086019 Secretin Proteins 0.000 description 1
- 102100037505 Secretin Human genes 0.000 description 1
- 102000005157 Somatostatin Human genes 0.000 description 1
- 108010056088 Somatostatin Proteins 0.000 description 1
- 108010010056 Terlipressin Proteins 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Natural products O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 1
- 108010050144 Triptorelin Pamoate Proteins 0.000 description 1
- GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001371 alpha-amino acids Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 238000010976 amide bond formation reaction Methods 0.000 description 1
- 125000006242 amine protecting group Chemical group 0.000 description 1
- 235000020616 amino acid formula Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 229960002403 atosiban Drugs 0.000 description 1
- 108700007535 atosiban Proteins 0.000 description 1
- VWXRQYYUEIYXCZ-OBIMUBPZSA-N atosiban Chemical compound C1=CC(OCC)=CC=C1C[C@@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CCCN)C(=O)NCC(N)=O)CSSCCC(=O)N1 VWXRQYYUEIYXCZ-OBIMUBPZSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 150000001576 beta-amino acids Chemical class 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229940106691 bisphenol a Drugs 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- CUWODFFVMXJOKD-UVLQAERKSA-N buserelin Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 CUWODFFVMXJOKD-UVLQAERKSA-N 0.000 description 1
- 229960002719 buserelin Drugs 0.000 description 1
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 108700008462 cetrorelix Proteins 0.000 description 1
- SBNPWPIBESPSIF-MHWMIDJBSA-N cetrorelix Chemical compound C([C@@H](C(=O)N[C@H](CCCNC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@H](C)C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC=1C=NC=CC=1)NC(=O)[C@@H](CC=1C=CC(Cl)=CC=1)NC(=O)[C@@H](CC=1C=C2C=CC=CC2=CC=1)NC(C)=O)C1=CC=C(O)C=C1 SBNPWPIBESPSIF-MHWMIDJBSA-N 0.000 description 1
- 229960003230 cetrorelix Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 238000012993 chemical processing Methods 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000007265 chloromethylation reaction Methods 0.000 description 1
- 229960001265 ciclosporin Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000003749 cleanliness Effects 0.000 description 1
- 238000003340 combinatorial analysis Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 229930182912 cyclosporin Natural products 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229960005408 deslorelin Drugs 0.000 description 1
- 108700025485 deslorelin Proteins 0.000 description 1
- 229960004281 desmopressin Drugs 0.000 description 1
- NFLWUMRGJYTJIN-NXBWRCJVSA-N desmopressin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(N)=O)=O)CCC(=O)N)C1=CC=CC=C1 NFLWUMRGJYTJIN-NXBWRCJVSA-N 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical class C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000002524 electron diffraction data Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- CZKPOZZJODAYPZ-LROMGURASA-N eptifibatide Chemical compound N1C(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CCCCNC(=N)N)NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@@H]1CC1=CNC2=CC=CC=C12 CZKPOZZJODAYPZ-LROMGURASA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 229960001527 felypressin Drugs 0.000 description 1
- SFKQVVDKFKYTNA-DZCXQCEKSA-N felypressin Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](N)CSSC1 SFKQVVDKFKYTNA-DZCXQCEKSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 150000002238 fumaric acids Chemical class 0.000 description 1
- 108700032141 ganirelix Proteins 0.000 description 1
- GJNXBNATEDXMAK-PFLSVRRQSA-N ganirelix Chemical compound C([C@@H](C(=O)N[C@H](CCCCN=C(NCC)NCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN=C(NCC)NCC)C(=O)N1[C@@H](CCC1)C(=O)N[C@H](C)C(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC=1C=NC=CC=1)NC(=O)[C@@H](CC=1C=CC(Cl)=CC=1)NC(=O)[C@@H](CC=1C=C2C=CC=CC2=CC=1)NC(C)=O)C1=CC=C(O)C=C1 GJNXBNATEDXMAK-PFLSVRRQSA-N 0.000 description 1
- 229960003794 ganirelix Drugs 0.000 description 1
- 238000012637 gene transfection Methods 0.000 description 1
- 229960002913 goserelin Drugs 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 102000058004 human PTH Human genes 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229940056984 integrilin Drugs 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 125000005928 isopropyloxycarbonyl group Chemical group [H]C([H])([H])C([H])(OC(*)=O)C([H])([H])[H] 0.000 description 1
- 108010021336 lanreotide Proteins 0.000 description 1
- 229960002437 lanreotide Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 1
- 229960004338 leuprorelin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960003837 lypressin Drugs 0.000 description 1
- 150000002689 maleic acids Chemical class 0.000 description 1
- 238000007567 mass-production technique Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910001092 metal group alloy Inorganic materials 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- RWHUEXWOYVBUCI-ITQXDASVSA-N nafarelin Chemical compound C([C@@H](C(=O)N[C@H](CC=1C=C2C=CC=CC2=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 RWHUEXWOYVBUCI-ITQXDASVSA-N 0.000 description 1
- 229960002333 nafarelin Drugs 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229920003986 novolac Polymers 0.000 description 1
- 229960002700 octreotide Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000002913 oxalic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 1
- 229960001723 oxytocin Drugs 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 230000007030 peptide scission Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000008298 phosphoramidates Chemical class 0.000 description 1
- 229940072644 pitressin Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920005593 poly(benzyl methacrylate) Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229960002101 secretin Drugs 0.000 description 1
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
- DUIOPKIIICUYRZ-UHFFFAOYSA-N semicarbazide Chemical compound NNC(N)=O DUIOPKIIICUYRZ-UHFFFAOYSA-N 0.000 description 1
- 238000005389 semiconductor device fabrication Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 1
- 229960000553 somatostatin Drugs 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 150000003443 succinic acid derivatives Chemical class 0.000 description 1
- 150000003444 succinic acids Chemical class 0.000 description 1
- 229940014800 succinic anhydride Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 229960003813 terlipressin Drugs 0.000 description 1
- BENFXAYNYRLAIU-QSVFAHTRSA-N terlipressin Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)CN)CSSC1 BENFXAYNYRLAIU-QSVFAHTRSA-N 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000005622 tetraalkylammonium hydroxides Chemical class 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- VXKHXGOKWPXYNA-PGBVPBMZSA-N triptorelin Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 VXKHXGOKWPXYNA-PGBVPBMZSA-N 0.000 description 1
- 229960004824 triptorelin Drugs 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 125000005500 uronium group Chemical group 0.000 description 1
- 229960003726 vasopressin Drugs 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0046—Sequential or parallel reactions, e.g. for the synthesis of polypeptides or polynucleotides; Apparatus and devices for combinatorial chemistry or for making molecular arrays
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00722—Communications; Identification
- G01N35/00732—Identification of carriers, materials or components in automatic analysers
-
- G—PHYSICS
- G03—PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
- G03F—PHOTOMECHANICAL PRODUCTION OF TEXTURED OR PATTERNED SURFACES, e.g. FOR PRINTING, FOR PROCESSING OF SEMICONDUCTOR DEVICES; MATERIALS THEREFOR; ORIGINALS THEREFOR; APPARATUS SPECIALLY ADAPTED THEREFOR
- G03F7/00—Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printing surfaces; Materials therefor, e.g. comprising photoresists; Apparatus specially adapted therefor
- G03F7/26—Processing photosensitive materials; Apparatus therefor
- G03F7/40—Treatment after imagewise removal, e.g. baking
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00351—Means for dispensing and evacuation of reagents
- B01J2219/00427—Means for dispensing and evacuation of reagents using masks
- B01J2219/00432—Photolithographic masks
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/005—Beads
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
- B01J2219/00531—Sheets essentially square
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/00497—Features relating to the solid phase supports
- B01J2219/00527—Sheets
- B01J2219/00533—Sheets essentially rectangular
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00545—Colours
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00547—Bar codes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00554—Physical means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00554—Physical means
- B01J2219/00558—Cuts-out
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00554—Physical means
- B01J2219/0056—Raised or sunken areas
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00563—Magnetic means
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00277—Apparatus
- B01J2219/0054—Means for coding or tagging the apparatus or the reagents
- B01J2219/00572—Chemical means
- B01J2219/00574—Chemical means radioactive
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/0059—Sequential processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00592—Split-and-pool, mix-and-divide processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00583—Features relative to the processes being carried out
- B01J2219/00596—Solid-phase processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00709—Type of synthesis
- B01J2219/00711—Light-directed synthesis
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00722—Nucleotides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
- B01J2219/00718—Type of compounds synthesised
- B01J2219/0072—Organic compounds
- B01J2219/00725—Peptides
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B60/00—Apparatus specially adapted for use in combinatorial chemistry or with libraries
- C40B60/14—Apparatus specially adapted for use in combinatorial chemistry or with libraries for creating libraries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
- G01N35/00722—Communications; Identification
- G01N35/00732—Identification of carriers, materials or components in automatic analysers
- G01N2035/00742—Type of codes
- G01N2035/00772—Type of codes mechanical or optical code other than bar code
Definitions
- the present invention relates to a process for the preparation of a particle for use in solid supported chemistry, to particles obtained by such a process, and to a plurality of uses of such particles.
- Combinatorial chemistry is a technique for generating large numbers of chemical compounds using relatively few chemical reaction steps. In tandem with high throughput screening, combinatorial chemistry has greatly accelerated the process of generating new compounds for leads as pharmaceuticals, agrochemicals and the like.
- solid support particles e.g. beads
- chemical entities such as, for example, polypeptides, carbohydrates, nucleotides and other oligomeric and non- oligomeric compounds
- such particles can be tagged to make them identifiable so that they may then be used to test various substances for the presence, or absence, of chemical entities in those substances.
- identifiable particles are especially useful for high throughput screening, combinatorial chemistry, genomic and proteomic scientific applications, much effort has gone into the development of tagging techniques used to provide or encode an identifiable particle, or set of identifiable particles, with an identifier.
- identifiers can be read following chemical interactions at the identifiable particles in order that the identifiers can be matched to those indicating the chemical entities in the chemical library or other chemical entities with which the library chemical entities interact.
- tagging techniques exist for tagging or coding identifiable particles, such as beads.
- particles can be coded using transponders (US5736332, US5981166, US6051377, US6361950, US6376187), magnetic tags, biological tags and various optical techniques.
- transponders US5736332, US5981166, US6051377, US6361950, US6376187
- magnetic tags magnetic tags
- biological tags and various optical techniques.
- PCR polymerase chain reaction
- Conventional optical techniques that are currently used to identify particles include the following: fluorescent tagging; infrared (IR) tagging; optical image pattern recognition (GB2306484); Raman tagging (J. Am. Chem. Soc, 25, 10546-10560 (2003)); and quantum dot encoding (Anal. Chem., 76, 2406-2410, (2004)).
- the support particle preferably comprises a first phase comprising a solid support suitable for use in combinatorial chemistry techniques, and a second phase containing a machine readable code.
- GB2334347 discloses a process for the preparation of coded particles comprising steps of
- the processes of this disclosure involves the etching of the silicon wafer (or other suitable solid) itself to form the particles.
- a preferred sacrificial layer is a 3 ⁇ m layer of photoresist. Release is effected using a diluted developer.
- a problem that remains is to provide particles suitable as supports for multi-step synthetic sequences.
- a further problem that remains is to provide improved particles suitable for use in solid supported chemical reaction sequences.
- a process for the preparation of a particle for use as a solid support in chemistry comprising
- a laminar support material comprising at least a sacrificial layer with a photopolymerisable material
- the sacrificial layer comprises a metal or metals.
- a particle of the invention as a support for solid supported chemistry.
- a particle of the invention in the preparation of an oligopeptide.
- a particle of the invention in the preparation of an oligonucleotide.
- a particle of the invention in the preparation of a chemical library.
- a process for the preparation of a library of compounds comprising steps of
- FIG. 1 shows particles according to embodiments of the present invention
- Figure 2 shows an identifiable particle according to an embodiment of the present invention
- Figure 3 shows scanning electron microscope (SEM) images of gratings that encode predetermined diffraction pattern identifiers according to embodiments of the present invention
- Figure 4 shows a plot of how encoding capacity varies with grating length for various gratings that encode predetermined diffraction pattern identifiers according to embodiments of the present invention
- Figure 5 shows schematically various one-dimensional and two-dimensional gratings that may encode predetermined diffraction pattern identifiers according to embodiments of the present invention
- Figure 6 illustrates a method of making a master template for producing particles according to an embodiment of the present invention
- Figure 7 illustrates a process for the preparation of particles according to an embodiment of the present invention
- Figure 8 illustrates an optional second part of a method of making tags for particles using a master template according to an embodiment of the present invention
- Figure 9 illustrates a method of making tags for particles according to an embodiment of the present invention
- Figure 10 illustrates a method of making tags for particles according to an embodiment of the present invention
- Figure 11 illustrates a method of making tags for particles according to an embodiment of the present invention
- Figure 12 schematically shows a reader for reading an identifier from particles according to the present invention in perspective view
- Figure 13 schematically shows the reader of Figure 12 in plan view
- Figure 14 schematically shows alternative detector positions in a reader for reading identifiers from particles according to the present invention.
- laminar support material refers to a material comprising one or more layers and having a substantially uniplanar face.
- the laminar material comprises at least a substrate material. More preferably, the substrate material comprises silicon or a glass material. Most preferably, the substrate material consists of silicon or a glass material.
- the layers may be held together using any suitable means.
- an intermediate adhesive layer may be necessary or expedient.
- the laminar support material may consist of only a sacrificial layer.
- the term "sacrificial layer” refers to the layer of the laminar support material which can be reduced in integrity in order to liberate the particle of the invention.
- the sacrificial layer of the present invention comprises a metal or metals.
- the metal may exist as a pure metal (i.e. a layer of elemental metal), as an alloy, or as a dispersion of metal particles within a matrix material.
- the sacrificial layer consists of a metal or an alloy of metals.
- the sacrificial layer comprises at least aluminium or chromium or both. More preferably, the sacrificial layer is an alloy comprising aluminium. More preferably, the sacrificial layer consists essentially of aluminium.
- sacrificial layers comprising a metal or metals results in a particle having markedly superior properties as a support for use in solid-supported chemistry, especially in multi-step reaction sequences.
- the thickness of the sacrificial layer is less than 1000 nm. More preferably, the thickness of the sacrificial layer is less than 500 nm. More preferably, the thickness of the sacrificial layer is less than 200 nm. More preferably, the thickness of the sacrificial layer is less than 100 nm. Most preferably, the thickness of the sacrificial layer is less than 50 nm.
- the thickness of the sacrificial layer is more than 1 nm. More preferably, the thickness of the sacrificial layer is more than 2 nm. More preferably, the thickness of the sacrificial layer is more than 5 nm. Most preferably, the thickness of the sacrificial layer is at least 10 nm.
- the thickness of the sacrificial layer is between 1 and 1000 nm. More preferably, the thickness of the sacrificial layer is between 5 and 100 nm. Most preferably, the thickness of the sacrificial layer is between 10 and 50 nm.
- the sacrificial layer is applied to the adjoining layer of the laminar support material by a sputtering process.
- sputtering refers to the process of dislodging atoms from a target material to coat a thin film onto a substrate.
- the term "photopolymerisable material” refers to a composition comprising at least one monomer which is capable of undergoing polymerisation when exposed to radiation.
- the photopolymerisable material is a u.v. polymerisable material. That is, the composition is capable of undergoing polymerisation when exposed to ultraviolet light.
- the photopolymerisable material is present as a solution for the purposes of coating on to the laminar support material.
- Suitable solvents include water and organic solvents.
- a preferred photopolymerisable material is SU-8.
- SU-8 comprises three components; an EPON epoxy resin, an organic solvent, and a photoinitiator.
- the EPON resin of SU-8 is a multifunctional glycidyl ether derivative of bisphenol-A novolac used to provide high-resolution patterning for semiconductor devices.
- the second component is gamma-butyrolactone (GBL), an organic solvent. The quantity of the solvent determines the viscosity of the solution, which determines final thickness of the spin- coated film.
- GBL gamma-butyrolactone
- cyclopentanone is also used as a solvent for SU-8.
- the third component is a triarylium-sulfonium salt, a photoinitiator which is approximately 10 wt % of EPON SU-8.
- SU-8 resin can be cationically polymerised by utilizing a photoinitiator which generates strong acid upon exposure to ultraviolet light (365 to 436 nm) and the acid facilitates polymeric cross-linking during post-exposure bake.
- reactive functional group refers to a chemical group present in the polymerised photopolymerisable material capable of reacting with a small molecule (i.e. one present in solution) to form a covalent bond.
- reactive functional groups are halogen (especially fluoro, chloro, bromo and iodo), hydroxy, carboxy (CO 2 H), carbonyl, amino, epoxy and thiol.
- the reactive functional group may be introduced subsequent to polymerisation of the photopolymerisable material.
- the polymerised material comprises unfunctionalised aromatic rings, it may be chloromethylated in a manner analagous to the preparation of Merrifield resins (R.B. Merrifield, J. Am. Chem. Soc. 85, 2149 (1963)).
- the polymerised photopolymerisable material possesses reactive functional groups without the necessity of introducing these subsequent to polymerisation.
- the photopolymerisable material comprises an epoxy resin (as in the case of SU-8)
- the polymerised material will comprise at least an amount of epoxy groups.
- the photopolymerisable material may be coated on the laminar support material using any appropriate technique. It may be applied as a sheet that is simply adhered to the laminar support material. If the polymerisable material is a liquid, it may be applied as a spray or aerosol. Alternatively, it may be painted on using a brush or roller. A preferred technique for coating the laminar support material with photopolymerisable material is spin coating.
- Spin-coating consists of dispensing photpolymerisable material solution over the wafer surface and rapidly spinning the wafer until it becomes dry. Typical spin- coating processes are conducted at final spin speeds of 3000-7000 rpm for a duration of 20-30 seconds.
- the thickness of the coat of photopolymerisable material is preferably between 0.1 and 100 ⁇ m, more preferably between 0.5 and 50 ⁇ m, still more preferably between 1 and 25 ⁇ m.
- a layer of adhesive or primer in order to achieve satisfactory binding of the support material to the photopolymerisable material.
- a primer comprises hexamethyldisilizane (such as Microposit primer).
- the laminar support material may be necessary to heat treat the laminar support material (for example at about 200 0 C for about 30 minutes) in order to effect dehydration. This also assists in achieving good adhesion of the photopolymerisable material to the laminar support material.
- a soft baking step is preferably employed.
- a soft bake is done to: i) drive away the solvent from the applied photopolymerisable material; ii) improve the adhesion of the photopolymerisable material to the laminar support material; and iii) anneal the shear stresses introduced during the coating.
- Soft baking may be performed using one of several types of ovens (e.g., convection, infrared, hot plate).
- Soft-bake ovens must provide well-controlled and uniformly distributed temperatures and a bake environment that possesses a high degree of cleanliness.
- the recommended temperature range for soft baking is between 90-100 0 C, while the exposure time heeds to be established based on the heating method used and the resulting properties of the soft-baked resist. These factors will be readily determined by one skilled in the art.
- the coated face is exposed to radiation
- the radiation is of a wavelength and intensity to cause regions of photopolymerisable material exposed to it to polymerise. These factors will be dependent on the nature of the photopolymerisable material, and the skilled person will be able to determine them.
- polymerisation is suitably achieved by exposure to ultraviolet (u.v.) radiation for between 1 and 30, preferably about 18 seconds, at an intensity of between 1 and 50 mw cm “2 , preferably about 13.6 mw cm “2 .
- u.v. ultraviolet
- the polymerised photopolymerisable material is subjected to one or more post exposure treatment steps in order to make the polymerised material more physically and chemically durable during later stages.
- the post exposure treatment steps comprise at least a post exposure bake. Such a post exposure bake serves to further cross-link the polymerised material and increase its strength and durability.
- the post exposure bake is conducted at about 65 0 C for about 1 minute, followed by about 95 0 C for about 5 minutes.
- the coated face of the laminar support material is exposed to radiation through a photolithographic mask.
- the principles of photolithography are well known from the field of semiconductor device fabrication.
- the photolithographic mask consists in essence of portions of material transparent to radiation, and portions of material opaque to radiation arranged in the desired pattern, such that when radiation is applied to the coated face of the laminar support material through the mask, the pattern is transposed onto the coated face.
- the photolithographic mask defines the size and shape of the particles by means of the above-mentioned transparent and opaque portions.
- the polymerised regions i.e. those exposed to radiation
- the unpolymerised regions are removed to leave the polymerised regions.
- This is referred to as "development”.
- the unpolymerised regions are removed.
- the unexposed photopolymerisable material is selectively removed from the coated laminar substrate by treatment with organic solvent.
- the organic solvent is polypropylene glycol methyl ether acetate (PGMEA). It is particularly convenient to immerse the laminar substrate in a bath of such a solvent.
- the skilled person will be able to determine the optimum duration of such a treatment step to ensure substantially complete removal of unexposed regions of photopolymerisable material while having little or no effect on the exposed regions.
- the coated laminar substrate may be washed to remove excess solvent.
- the developed coated laminar substrate may be subjected to a post-development bake.
- the development step discloses or reveals portions of sacrificial material between the residual polymerisable material (i.e. the adhering particles).
- Figure 7 illustrates a process for the preparation of particles of the invention.
- a layer of photopolymerisable material 75 is coated on to a thin layer of sacrificial material 76 on a substrate layer 70.
- a mask is superimposed on the layer 75, and the whole is exposed to radiation.
- the layer of photopolymerisable material is selectively exposed through transparent and opaque 71 regions of mask 72.
- the mask 72 is removed, leaving polymerised 73 and unpolymerised regions of photopolymerisable material.
- unpolymerised material is removed in a development process to leave particles 73 (i.e. regions of polymerised material) adhering to sacrificial material 76.
- the integrity of the sacrificial material 76 is reduced to liberate the particles.
- the developed coated laminar substrate comprises particles of the invention adhering to the laminar substrate.
- the integrity of the sacrificial layer is reduced.
- Reduction of the integrity of the sacrificial layer may be achieved by any one of a number of means. In a broad sense, any degree of reduction of integrity is acceptable provided that it serves to liberate the particles from the laminar support material.
- the integrity of the sacrificial layer is reduced by at least partially dissolving the metal component.
- the metal component may be at least partially dissolved by treating the developed coated laminar substrate with an etch. Suitable etches for a variety of metals are known, and the skilled person will be able to select an appropriate one.
- the etch comprises hydroxide ions. Highly preferably, the etch comprises tetraalkylammonium hydroxide. Very highly preferably, the etch comprises tetramethylammonium hydroxide.
- a highly preferred etch is Microposit MF 319 developer, available from Rohm and Haas. This is an aqueous solution comprising 97-98 wt. % water, 0.1 - 1 wt. % surfactant and balance tetramethylammonium hydroxide.
- the particles are liberated by immersing the developed coated laminar substrate in the etch.
- the liberated particles are then removed by filtration and washed.
- the developed coated laminar substrate is immersed in the etch for a period of less than 1 minute. More preferably, the developed coated laminar substrate is immersed in the etch for a period of less than 30 seconds. More preferably, the developed coated laminar substrate is immersed in the etch for a period of less than 20 seconds. More preferably, the developed coated laminar substrate is immersed in the etch for a period of less than 10 seconds. It has been found that a reduction in the time the particles are exposed to the etch results in improved performance of the particles as substrates for solid supported chemistry.
- the thickness of the particles will be chiefly determined by the thickness of the coat of photopolymerisable material originally applied to the laminar substrate.
- the photolithographic mask determines the ultimate shape of the particles in the remaining two dimensions once liberated from the laminar substrate.
- the particles may be of any desired size and shape that is convenient for the intended end use.
- the particles are of square or rectangular cross section. More preferably, the particles are rectangles of from 1 to 500 ⁇ m by 1 to 500 ⁇ m.
- the particles may comprise an encoded identifier, or tag, which enables the individual particles to be distinguished from one another.
- the particles of the invention are encoded by means of their shape. Such a scheme is described in US2003/0153092, which is incorporated herein by reference in its entirety.
- each particle may be encoded by pits, grooves, notches, bumps, ridges or by fluorescent, coloured or monochrome markings (for example, bar codes). Any conventional technique may be used to apply such encoding motifs, for example by printing. Alternatively, magnetic or radiofrequency identifiers may be incorporated or attached.
- the particles may also be encoded using Raman barcoding, comprising spectroscopic bar codes that incorporate infrared and Raman-active groups that are identifiable using standard infrared or Raman spectrometers.
- Raman barcoding comprising spectroscopic bar codes that incorporate infrared and Raman-active groups that are identifiable using standard infrared or Raman spectrometers.
- Encoding may be performed at any stage of the preparation of the particles.
- the photolithographic mask comprises encoding means, so that encoding occurs during exposure of the photopolymerisable material to radiation.
- the particles are encoded by embossing features into the photopolymerisable layer by means of a rigid stamp. This technique is referred to as nanoimprinting.
- the encoding of the particle can be achieved by embossing, imprinting, injection moulding, laser ablation or direct write (e-beam) techniques.
- encoding occurs in a secondary coating / exposure / development sequence subsequent to development of the primary coating (i.e. after step iii).
- the exposed and developed layer of photopolymerisable material is coated with a secondary coat of photopolymerisable material.
- the coated face is exposed to radiation through a second photolithographic mask, and developed in a similar manner to that described above.
- the particles are encoded with a diffraction pattern identifier such that the particles give an identifiable diffraction pattern when exposed to a particular wavelength of radiation.
- the diffraction pattern identifier may be encoded by material variations provided in the particle material. Smoothly changing or stepped transparent refractive index variations may be used to provide patterns of material variations. Non-transparent materials may also be used where patterned material variations are provided in one or both of the absorptive strength or the reflectivity of the material. Reflective features may also be used.
- Various techniques can be used to provide material variations, such as, for example, embossing using a master template, nano-imprinting, laser- ablation, injection moulding, etching with a high energy beam, writing an interference pattern using an optical interference technique, or applying a pattern using a lithography technique. Such techniques lend themselves well to relatively rapid, simple and cheap mass production techniques that may be used when manufacturing identifiable particles.
- the localised distribution of the material variations may be used to encode a predetermined diffraction pattern identifier that may be used for identifying the particle.
- a diffraction pattern identifier is chosen from a number of possible diffraction pattern identifiers that could be encoded into the particle during its manufacture using a common encoding scheme.
- Each unique pattern of material variations in a particle which are provided according to the encoding scheme gives rise to a unique diffraction pattern.
- Such diffraction patterns are particularly suited to various forms of digital processing, since a large number of possible permutations in a spatially distributed pattern can be obtained using the same type of pattern of material variations provided by a particular encoding scheme.
- One example of an encoding scheme uses increasing numbers of superimposed refractive index gratings provided in the same physical space in a particle material to provide increasingly complex diffraction patterns. By increasing the number of superimposed gratings, such an encoding scheme enables an increasingly large number of different diffraction pattern identifiers to be encoded.
- identifiers may be read by exposing the particle to various types of radiation such as, for example, optical radiation. Since in this embodiment the particle relies on diffraction techniques to provide the identifier, it need not rely upon near-field imaging techniques for particle reading and the material variations used to encode the identifier may be smaller in size than the wavelength of any exposing radiation that is used to read the identifier. This also means that a large number of different identifiers can be encoded in a relatively small volume of particle material.
- a reader for identifying the particles may be sited remotely from the particles themselves. This has practical benefits for readers that are designed to read identifiers from the particle. Moreover, since the material variations that give rise to diffraction can be provided within the particle itself, no separate identifier-bearing tags need be attached to make particles identifiable.
- a method of making particles comprising selecting a diffraction pattern identifier from a plurality of diffraction pattern identifiers that can be encoded using the same identifier encoding scheme, determining the material variations needed to encode the diffraction pattern identifier, and providing the material variations in a particle material to form a particle. Many particles having the same or different identifiers may be made, as desired.
- kits for detecting the presence of a predetermined chemical entity comprising a plurality of particles.
- a kit may be used to "sift" genes or proteins in search of new drugs or drug targets.
- DNA sequences oligomers
- antibodies, peptide sequences, or other proteins or small molecules the particles can home in on target molecules, tagging them with one or more identifiers that can subsequently be read.
- Such molecules may additionally be labelled with some other secondary molecule, such as, for example, a fluorescent tag, a magnetic tag, or an alternative means of identification.
- a reader for reading a predetermined diffraction pattern identifier from a particle.
- the reader comprises a source for exposing particles to radiation, a detector for detecting the diffraction pattern of radiation emitted from the particles, and an analyser for analysing the diffraction pattern of the radiation emitted from the particles in order to determine whether the diffraction pattern corresponds to a diffraction pattern identifier encoded according to a predetermined encoding scheme.
- the analyser comprises a data processing apparatus that uses one or more of: hardware components, firmware components, and software components.
- a method for reading a predetermined diffraction pattern identifier from a particle comprises exposing a particle to radiation, detecting the diffraction pattern of radiation emitted from the particle, and analysing the detected diffraction pattern in order to determine whether it matches a diffraction pattern identifier encoded using a predetermined encoding scheme.
- a method for identifying a chemical entity in a test substance comprises introducing a plurality of particles comprising a plurality of predetermined receptor materials into the test substance, wherein respective different predetermined receptor materials bind to respective different predetermined chemical entities.
- the method also comprises reading the respective predetermined diffraction pattern identifiers of the particles that have bound to respective chemical entities, and matching the identifiers that are read to respective predetermined chemical entities so as to identify the chemical entities present in the test substance.
- Such a method may be used in the search for new drugs or drug targets, or for rapid parallel sequencing of nucleic acids, analogues of nucleic acids or modified nucleic acids. Moreover, the use of these particles can remove the need to perform PCR and gel migration steps when sequencing methods are performed.
- the method may also be used to screen for proteins, to detect the binding of proteins to various immobilised bio-molecules or to detect proteins through interactions with bound ligands. It may be used to screen libraries for the activity of different agents, and peptide libraries may be grown or immobilised upon the particles.
- Figures 1a-d show particles 10a-d.
- the particles 10a-d are made of a particle material 12.
- a grating 16 that encodes a predetermined diffraction pattern identifier by providing a predicable diffraction pattern when exposed with laser-generated radiation.
- Figure 1a illustrates a single one dimensional grating 16a provided in particle 10a;
- Figure 1 b two overlapping one dimensional gratings 16b provided in particle 10b;
- Figure 1c a double overlapping two dimensional grating 16c provided in particle 10c;
- Figure 1d a complex pattern diffraction grating 16d provided in particle 1Od.
- the gratings 16 can be provided by inclusion of non-particle material 17 (as shown in Figure 1e) or by providing a relief pattern 18 in the particle material 12 (as shown in Figure 1f).
- the grating 16 may be written directly into the particle material 12 using techniques such as direct interference writing or by embossing the particle during manufacture.
- a particle 10 is further shown with a coating of receptor material 14 for binding to a predetermined chemical entity.
- the receptor material 14 is placed over the grating 16. It has been found that the grating 16 provides a suitable site for the stable hosting of various receptor materials 14 for use in combinatorial chemistry. Many types of receptor material 14 can be provided for binding to various nucleic acids, polypeptides, carbohydrates and other oligomeric compounds, for example.
- chemical entities bind to the receptor material 14 and, since the particle 12 can be uniquely identified, the reaction can be observed in situ whilst also being distinguished from any other reactions between different particles and their target chemical entities.
- the receptor material 14 is an oligonucleotide that binds to a nucleic acid, an analogue of a nucleic acid or a modified nucleic acid
- a highly parallel approach to sequencing is made possible, whereby a large number of particles having different receptor materials can be placed into a test substance, selectively bind to components in the test substance and subsequently be identified (for example, a large plurality greater than 10, 10 2 , 10 3 , 10 4 , 10 5 , 10 6 , 10 7 , etc. of uniquely particles may be provided).
- This enables, for example, sequencing of nucleic acids, such as D N A/RN A/protein nucleic acids, to be performed rapidly and with minimal cost and effort.
- the particle material 12 may incorporate various formations that can be attached to a further particle (not shown).
- Such a further particle may be coated in receptor material so that the particle 10 acts as a tag that is separated from the active receptor material.
- further particles may comprise coated spherical latex beads or the like to which tags comprising particles can be attached.
- the particles 10 may be manufactured from materials that enable the identifier to be determined only after exposure to some form of radiation, heat, chemical change (e.g. pH or salt concentration) or developing agent.
- the identifier may be erased following exposure to radiation, heat, pH or electrolyte concentration.
- Figure 2 shows a particle 20.
- the particle 20 is made of a particle material 22 embossed with a master made using a phase grating 26 that encodes a predetermined diffraction pattern identifier.
- the particle material 22 is of elongate shape having a longest dimension D. Typically D will lie in the range from about 100 nm to about 10 ⁇ m.
- the particle material 22 is additionally coated with a receptor material 24 for binding to a predetermined chemical entity.
- FIG. 3 shows scanning electron microscope (SEM) images of gratings 30, 32, 34 that encode respective predetermined diffraction pattern identifiers.
- the gratings are created by using direct writing electron-beam lithography to provide a pattern on a PMMA film, provided on a metal-coated silica substrate, followed by a standard Deep Reactive Ion Etching (DRIE) process. Information relating to the identifier is encoded by the grating period.
- the pattern that is written comprises a superposition of separate gratings each having a different periodicity.
- Figure 4 shows a plot 40 of how encoding capacity of grating-based identifiers varies with grating length for various different gratings 41, 43, 45, 47, 49 that encode predetermined diffraction pattern identifiers.
- the encoding capacity is calculated as the number of bits of information that the particular grating 41 , 43, 45, 47, 49 can encode and is calculated assuming that the gratings are to be read using optical radiation having a wavelength of 532 nm.
- the plot 40 shows how the encoding capacity increases by some five orders of magnitude when the grating changes from a single period grating 41 having a length of about 100 ⁇ m to a grating 49 comprising five superimposed single period gratings having an overall length of about 100 ⁇ m.
- Figure 5 shows schematically various one-dimensional and two-dimensional gratings 52, 54, 56, 58 that may be used to encode predetermined diffraction pattern identifiers in particles or tags for attaching thereto.
- the first grating 52 has a length di and comprises a regularly spaced series of either reflective and less reflective elements or a series of alternating refractive index materials of pitch p.
- the second grating 54 has a length d-i and is formed by two linearly superimposed gratings having respective pitches of P 1 and p 2 .
- the third grating 56 is based upon a two dimensional pattern of size d-i x d 2 , and is formed by two orthogonally superimposed gratings having respective pitches of pi and p 2 .
- the fourth grating 58 is also based upon a two dimensional pattern of size di x d 2 , but is not formed of regular gratings, comprising instead a predetermined arbitrary pattern that gives rise to a calculable (or measurable) far-field diffraction pattern identifier. Use of such two-dimensional patterning for gratings enables an even larger number of identifiers to be encoded with particles.
- Figure 6 illustrates a method of making a master template 60 for producing particles.
- the master template can be used for embossing a pattern that provides a particle with an identifier.
- the pattern can have sub-micron feature sizes that cannot be made directly by simple or conventional photolithography.
- the master template 60 is created from a pre-form 61.
- the pre-form 61 comprises a substrate 62 made of silicon or glass.
- the substrate is coated in a thin layer of chromium 64 ( ⁇ 100 nm thick) overlaid with a layer of electron-beam sensitive resist 66.
- the required pattern may be designed using a computer-aided design (CAD) package, such as, for example, AutoCADTM available from Autodesk, Inc. of San Rafael, CA, USA. Such a pattern defines the variations needed to encode a particular predetermined diffraction pattern identifier.
- CAD computer-aided design
- Figure 7 illustrates a process for the preparation of a particle of the invention as described above.
- FIG 8 illustrates a method of making tags 73" for use with particles using a master template 60.
- the tags 73' may be made from a polymer material such as SU8 (which is an Epoxy-based resist that can be used to produce high aspect ratio features), or polyimide or PMMA or some other resist material, for example.
- the tags 73' may be embossed into sheets or rolls of plastic material on a production line. A two step process is used, one to define the extent of the tags 73' (shown in Figure 7) and another to encode an identifier onto the tags 73' (shown in Figure 8).
- Figure 8 shows how an identifier is encoded by nano-imprint lithography or nano- embossing onto the bare tags 73 produced on the substrate 70 using the method shown in Figure 7 and described above.
- a thin second layer of SU8 (e.g. 0.5 ⁇ m to 2 ⁇ m) is deposited over the bare tags 73.
- the substrate 70 comprising the bare tags 73 is spun at 500 rpm for 5 seconds, accelerated to 1000 rpm within 5 seconds and kept at 1000 rpm for 30 seconds, followed by the soft-baking process already described.
- the second layer of SU8 is exposed to remove the material between bare tags 73, at stage 6.
- the substrate 70 is exposed to L)V light for 24 seconds through the mask 72 (appropriately aligned) and then post-exposure baked at 9O 0 C for 15 minutes on a hotplate.
- a development step is then carried out in SU8 developer for 2 to 7 minutes with periodic rinsing in IPA.
- the substrate 70 is blow-dried with nitrogen leaving a thin layer of SU8 on the bare tags 73.
- the bare tags 73 are then embossed to impart a pattern and convert them into tags 73" that encode a predetermined diffraction pattern identifier.
- a silicon or metal master template 60 is aligned and brought into contact with the substrate 70 before external pressure is applied (e.g. 50 kg/cm 2 at 8O 0 C).
- external pressure e.g. 50 kg/cm 2 at 8O 0 C.
- the template is released and the substrate 70 is hard baked to affix the embossed pattern encoding the identifier into the tags 73'.
- the hard baking process is performed at an elevated temperature lower than the Tg of the material in which the pattern is embossed. For example, for poly(benzyl methacrylate) hard baking could be performed at 54 0 C, whereas for poly(cyclohexyl acrylate) it could be performed at 100 0 C.
- Figure 9 illustrates a method of making tags 83 for use with particles using a combined photolithography and nano-imprint lithography technique.
- a glass or silicon wafer 80 is processed as per conventional lithography, i.e. cleaned etc.
- the surface is then coated with a release agent.
- the release agent provides layer of a sacrificial layer 86 that comprises one or more layers of metal (e.g. aluminium or chromium), together with layers of photoresist (e.g. S1818), or a thin coating of TeflonTM or any combination thereof.
- a layer of SU8 85 (for example of the order of 1 to 25 ⁇ m thickness) is disposed over a thin layer of sacrificial material 86 onto the substrate 80, which has been pre-baked at 200 0 C for 30 minutes for dehydration purposes.
- the substrate is spun at 500 rpm for 10 seconds, then accelerated to 2500 rpm within 10 seconds and keep at 2500 rpm for 10 seconds. Then it is soft-baked on a hotplate at 9O 0 C for 20 minutes until the SU8 film is no longer sticky following a slow cooling.
- a mask 82 is pressed onto the layer of SU8 85.
- the mask 82 is similar to that described above, with the exception that it comprises embossing formations 87 for forming a pattern that encodes an identifier onto the tags 83.
- the layer of SU8 85 is imprinted, for example at 8O 0 C and a pressure of 50kg/cm 2 .
- the layer of SU8 85 is exposed to a suitable wavelength (e.g. 365 nm) through the mask 82 in order to cross link the exposed SU8. Following post-exposure baking on a hotplate for some minutes, the mask 82 and substrate 80 are separated.
- the layer of SU8 85 is developed as normal to remove any unexposed resist 88.
- This provides a substrate 80 supporting one or more tags 83 that can subsequently be released by etching the sacrificial material 86 or by being diced and then released as desired.
- Figure 10 illustrates a method of making tags 93 for use with particles using a UV initiated imprinting technique.
- a glass or silicon wafer 90 is processed as per conventional lithography, i.e. cleaned etc.
- the surface is then coated with a release agent.
- the release agent provides layer of a sacrificial layer 96 that comprises one or more layers of metal (e.g. aluminium or chromium), together with layers of photoresist (e.g. S1818), or a thin coating of TeflonTM or any combination thereof.
- a layer of SU8 95 (for example of the order of 1 to 25 ⁇ m thickness) is disposed over a thin layer of sacrificial material 96 onto the substrate 90, which has been pre-baked at 200 0 C for 30 minutes for dehydration purposes.
- the substrate is spun at 500 rpm for 10 seconds, then accelerated to 2500 rpm within 10 seconds and keep at 2500 rpm for 10 seconds. Then it is soft-baked on a hotplate at 9O 0 C for 20 minutes until the SU8 film is no longer sticky following a slow cooling.
- UV initiated imprinting can also be used, by providing a low viscosity resist 99 having embossing formations 97 formed thereon for forming a pattern that encodes an identifier onto the tags 93.
- the resist 99 is provided between the mask 92 and the substrate 90 supporting the layer of SU8 95.
- the resist 99 may be placed on the mask 92, and the mask 92 brought into contact so that the resist 99 spreads under the influence of surface tension.
- UV light is used to cross-link the resist 99 so as to define a pattern that encodes the desired identifier(s) when the mask is released from contact with the substrate 90.
- the tags 93 can be processed to make them chemically active. This can be done whilst they are still in situ on the substrate 90, e.g. using robot "spotting", or by directed growth of compounds, e.g. using a robot or light mediated synthesis. Alternatively, the tags 93 may be released from the substrate 90 and processed as described herein.
- Figure 11 illustrates a method of making tags for particles.
- Figure 11 shows a similar method to that shown in figure 10, with the difference that a low viscosity resist 91 is used.
- Figure 12 schematically shows a reader 100 for reading identifiers 116 from particles
- the reader 100 comprises a source 160 that generates a laser beam of infrared
- IR near-infrared
- NIR near-infrared
- the source 160 preferably operates using optical radiation at 630 nm.
- use of a shorter wavelength such as, for example, 530 nm, would allow the reader 100 to work with particles 110 that have a higher encoding capacity.
- ultra-violet light could be used in various applications, its effect on various biological molecules, by way of inducing chemical reactions and degradation, may make it unsuitable for use with certain receptor materials.
- Use of IR or NIR radiation e.g. from about 650 nm to about 1000 nm, is particularly useful for biological applications since it corresponds to a wavelength window in which radiation can penetrate cells without causing cell damage.
- a diffraction-pattern based tag that encodes an identifier may be read by an electron beam.
- a tag can comprise material variations that are provided on a scale that is even smaller than for an optically-based tag.
- the material variations can be provided on a scale that is of the same order as the de Broglie wavelength of the electrons, in order to obtain a characteristic electron diffraction pattern.
- the detector 120 comprises a CCD array 122, which is ideally suited to detecting the two-dimensional spatial distribution pattern that encodes the identifiers.
- the detector 120 can detect a diffraction pattern spatial distribution of radiation emitted from the particles 110, and can therefore be sited remotely from the region 164.
- the detector 120 also comprises a high numerical aperture lens 124 that enhances the amount of light that can be collected, and which therefore enables the diffraction pattern radiation pattern to be detected using a relatively short signal integration time. This speeds detection and is thus useful when large numbers of particles 110 need to be rapidly identified.
- the output from the detector 120 is analysed by analyser 150 to determine whether the spatial pattern matches that of any known predetermined identifier.
- the analyser 150 comprises a computer system that is programmed to match a diffraction pattern map from the detector 120 with corresponding records of known identifiers 116 stored in a database.
- the records in the database associate the known identifiers 116 with any chemical receptors, treatments etc. that have been imparted to the particles 110.
- the particles 110 transported through the region 164 in a fluid, such as air or water, for example.
- a micro-fluidic transport channel 130 is used to guide the particles 110 suspended in the fluid from a storage tank (not shown), via an electrokinetic orientation device 170, through the region 164 and into a micro-sorter 140 (e.g. of the type available from Partec Gmbh of M ⁇ nster, Germany).
- a micro-sorter 140 e.g. of the type available from Partec Gmbh of M ⁇ nster, Germany.
- the electrokinetic orientation device 170 orientates the particles 110 toward a predetermined direction, so that they are all aligned in substantially the same direction with their largest dimension parallel to the bore of the micro-fluidic transport channel 130.
- the bore is configured to prevent the particles 110 from rotating by a large amount so that they remain oriented in substantially the same direction as they are transported through the region 164. This reduces the amount of processing that is required to determine the identifiers, since it helps ensure that the measured diffraction pattern patterns from different particles 110 are directly comparable with those used for matching at the analyser 150.
- the reader 100 may additionally, or alternatively, include a means for identifying the spatial orientation of the particles 110.
- the identifiers 116 can be encoded using a variety of encoding strategies, such as those illustrated schematically in Figure 5, which are discussed further below.
- the analyser 150 may be programmed to identify one or more type of particle having an identifier encoded according to one or more of these encoding strategies.
- a single grating of varying optical density, reflectivity, refractive index or height is provided.
- the encoding capacity ⁇ i.e. the number of different distinguishable identifiers
- a third encoding strategy superimposed gratings are provided in two different directions with pitches pi and p ⁇ .
- Identifier information is encoded in the values of pitches, and is read by detecting two diffracted beams at various angles in different planes.
- a complex pattern for instance one that is computer generated to give a certain distinct diffraction pattern
- Identifier information is read by detecting a complex diffraction pattern.
- Figure 13 schematically shows the reader 100 as a stream of particles 110 are passed through the region 164.
- a two-dimensional Fourier transform analysis of the diffraction pattern measured by the CCD array 122 is used by the analyser 150 to map the spatial diffraction pattern into k-space in order to determine the identifier.
- the analysis of the diffraction pattern is not sensitive to the motion of particles 110 parallel to the plane containing the CCD detector 122 and is also insensitive to the actual position of the particles 110 relative to the CCD array 122.
- Figure 14 schematically shows alternative detector positions in a reader 200 for reading identifiers from particles comprising a diffraction encoding structure 203.
- One or more reading optical beam 201 are shown, which may comprise beams at different wavelengths.
- the optical beam 201 is conditioned by an optical element 202 that comprises a lens, a spatial filter and a mask.
- the conditioned optical beam 201 is then incident upon the diffraction encoding structure 203.
- Various diffracted beams are generated, including backwardly diffracted beams a', b", c 1 and d 1 and forwardly diffracted beams a, b, c and d.
- the various diffracted beams may provide a continuous distribution of light.
- a first optical element 204 is shown which conditions the forwardly diffracted beams a, b, c and d and couples them to a first detector 205.
- a second optical element 206 which conditions the backwardly diffracted beams a 1 , b 1 , c 1 and d 1 and couples them to a second detector 207.
- One or more of these optical arrangements may be used in various readers provided as embodiments of the present invention.
- Various readers described herein may be used as the basis of a device that identifies particles and acts upon the identity of the particles to sort them into various outlet channels. Such a device may be used for combinatorial chemical synthesis applications. For example, where combinatorial analysis of oligonucleotide sequences is performed, particles can be identified and sorted into one of four outlets corresponding to the bases of DNA (ACGT).
- ACGT bases of DNA
- Identifiable particles having feature sizes greater than about 100-200 nm for encoding identifiers may be manufactured in various materials, such as, for example, polymers, using direct write laser ablation methods. Particles may also be manufactured using holographic phase writing techniques. For example, two or more crossed laser beams may be used to produce an interference pattern with characteristic period less than the wavelength of the laser light. These methods may be used to write patterns of diffraction gratings into polymers, for example. They may also be used as a direct write method for providing patterns encoding identifiers in photo-active polymers, for example.
- no receptor material may be provided, or a coating applied that is not for binding to a predetermined chemical entity.
- Such particles may be used with a detection system that checks for the presence or absence of particles.
- a detection system that checks for the presence or absence of particles.
- genuine articles such as, for example, vehicle parts
- a "dust" made up of one or more particles. The absence of such "dust” from manufactured articles may thus indicate that the articles are counterfeit, whilst the presence of such a "dust” could indicate that they are genuine.
- readers may be made which use relative movement between particles and a detector, including those in which the detector is movable and the particles remain stationary. Additionally, they will be aware that techniques other than electrokinetic/electrostatic orientation may be used to orientate particles. In addition, they will be aware that reader devices may be operable to identify chemical entities as well as identifiers encoded by a diffraction pattern. Such chemical entities may be identified, for example, using one or more of fluorescence, FRET, Raman, magnetic, electrokinetic, etc. techniques.
- the diffraction pattern identifier may be identified by analysing the diffraction pattern produced by the particle in momentum space, or k-space. Such a diffraction pattern identifier may be derived by calculating a Fourier transform of a spatial distribution of at least part of a diffraction pattern, which can then be compared to previously determined diffraction pattern identifiers in order to uniquely identify the particle.
- particles of the type described herein may be used in combination with various other techniques (e.g. with nano-particles, magnetic techniques, etc.)
- the particles may be wrapped around magnetic bar codes or incorporated into other elements such as, for example, chemicals for providing drug release at targeted sites. Such drugs could be released in response to exposure to radiation, for example.
- the particles may be made radioactive and used to target tumours, or contain DNA or drugs that are released at specific sites in a body or cell. They may, for example, contain other particles, such as QDS, for release at specific sites. Further, the particles may be used for non-viral gene transfection.
- multi-colour/colour-selective CCD arrays may be used in various reader embodiments. These can be used simultaneously to distinguish and detect several different wavelength components, thereby increasing reader capacity and improving error-correction capabilities.
- the particles may bear reactive functional groups or may have these introduced as described above, for example by chloromethylation.
- the particles are further functionalised by reaction with a functionalising agent.
- the term "functionalising agent” refers to a reagent or mixture of reagents which are capable of reacting with the reactive functional groups to render the particles more suitable for use as a solid support in subsequent reaction sequences.
- Examples of functionalising agents are those comprising thiols, alcohols, and amines.
- the functionalising agent comprises one or more amines.
- the amine is selected from ammonia, alkylamines and arylamines (anilines).
- the amine comprises one, two, three or more than three amine groups.
- the amine is a polyoxyalkyleneamine or polyether amine.
- a more preferred amine is a Jeffamine.
- a still more preferred amine is Jeffamine 8 oo-
- the reactive functional group is an epoxide
- the functionalising agent is an amine
- the functionalised particles will bear amine groups that are capable of undergoing further reaction.
- a linker group may optionally be attached.
- linker group refers to a chemical moiety capable of forming a chemical bond with both the particles (optionally functionalised) and partaking in further chemical reactions.
- the linker group is cleavable at the end of the reaction sequence to furnish the desired product.
- the linker group is introduced by reaction of the optionally functionalised particles with a compound containing at least two functional groups.
- Suitable linker groups are those derived from amino acids (for example ⁇ amino acids such as the natural amino acids, ⁇ amino acids, ⁇ amino acids, ⁇ amino acids, 1 ,5 amino acids and 1 ,6 amino acids), dicarboxylic acids (such as oxalic, maleic, fumaric and succinic acids), and derivatives and protected versions thereof.
- amino acids for example ⁇ amino acids such as the natural amino acids, ⁇ amino acids, ⁇ amino acids, ⁇ amino acids, 1 ,5 amino acids and 1 ,6 amino acids
- dicarboxylic acids such as oxalic, maleic, fumaric and succinic acids
- the linker is an amino acid.
- a preferred linker group is 6- aminohexanoic acid.
- a linker group bearing a carboxylic acid moiety is conveniently introduced using standard amide coupling conditions. Suitable techniques are described in "The Chemical Synthesis of Peptides" by J Jones, Oxford University Press, 1994.
- the linker group is attached by reaction of the particles with N-protected 6- aminohexanoic acid, or a reactive derivative thereof, followed by subsequent deprotection.
- the protecting group is fluorene-9-yl methoxycarbonyl (FMOC).
- FMOC fluorene-9-yl methoxycarbonyl
- Suitable reactive derivatives are those formed by the reaction of the N- protected 6-aminohexanoic acid with a diisocyanate (particularly hexamethyldiisocyanate (DIC)), or hydroxybenzotriazole (HOBt).
- the linker group is derived from a hydroxycarboxylic acid (a molecule possessing both a hydroxyl and carboxylic acid group).
- a highly preferred hydroxycarboxylic acid group is 4-hydroxymethyl-phenoxy acetic acid (HMPA).
- HMPA may be coupled to particles bearing reactive amine groups using standard amide bond formation conditions as described above. Solid supported synthesis
- the particles of the invention may be used as supports in an identical manner to conventional solid supports.
- the particles of the invention are amenable to multi-step synthetic sequences, and provide products in good purity and yield.
- a typical solid phase peptide synthesis scheme involves attaching a first amino acid or peptide group to the particles of the invention via the carboxyl moiety of the peptide or amino acid. This leaves the amine group of the resin bound material available to couple with additional amino acids or peptide material. Thus, the carboxyl moiety of the additional amino acid or peptide desirably reacts with the free amine group of the particle bound material. To avoid side reactions involving the amine group of the additional amino acid or peptide, such amine group is masked with a protecting group during the coupling reaction. Two well-known amine protecting groups are the BOC group and the FMOC group. Many others also have been described in the literature.
- the protecting group on the N-terminus of the resin bound peptide may be removed, allowing additional amino acids or peptide material to be added to the growing chain in a similar fashion.
- reactive side chain groups of the amino acid and peptide reactants, including the particle bound peptide material as well as the additional material to be added to the growing chain typically remain masked with side chain protecting groups throughout the synthesis.
- the desired peptide may be liberated from the particles. Suitable conditions for this liberation step depend on the nature of the particle and in particular the linker group as defined above (where present). The skilled person will be able to determine conditions for the liberation of the peptide.
- a preferred class of peptides of the present invention are those that incorporate from about 2 to about 100, preferably from about 4 to about 50, residues of one or more amino acids. Residues of one or more other monomeric, oligomeric, and/or polymeric constituents optionally may also be incorporated into a peptide. Non-peptide bonds also may be present. For instance, the peptides of the invention may be synthesized to incorporate one or more non-peptide bonds. These non-peptide bonds may be between amino acid residues, between an amino acid and a non-amino acid residue, or between two non-amino acid residues. These alternative non-peptide bonds may be formed by utilizing reactions well known to those in the art, and may include, but are not limited to imino, ester, hydrazide, semicarbazide, and azo bonds.
- the principles of the present invention may be advantageously used to synthesise the following peptide material, fragment intermediates thereof, and/or analogs from a particle after solid phase synthesis: enkephalins, oxytocin, vasopressin, felypressin, pitressin, lypressin, desmopressin, terlipressin, atosiban, adrenocorticotropic hormone, insulin, secretin, calcitonins, luteinizing hormone-releasing hormone (LH- RH) and analogues, leuprolide, deslorelin, triptorelin, goserelin, buserelin, nafarelin, cetrorelix, ganirelix, parathyroid hormone, human coriticotropin-releasing factor, ovine coriticotropin-releasing factor, growth hormone releasing factor, somatostatin, lanreotide, octreotide, thyrotropin releasing hormone (TRH), thy
- protecting groups for peptide synthesis is well known in the art.
- a suitable protecting group is any sort of group that can help prevent the atom or moiety to which it is attached, e. g. , oxygen or nitrogen, from participating in undesired reactions during processing and synthesis.
- Protecting groups include side chain protecting groups and amino-or N-terminal protecting groups. Protecting groups can also prevent reaction or bonding of carboxylic acids, thiols and the like.
- a side chain protecting group refers to a chemical moiety coupled to the side chain (i.e., R group in the general amino acid formula H 2 N-C(R)(H)-COOH) of an amino acid that helps to prevent a portion of the side chain from reacting with chemicals used in steps of peptide synthesis, processing, etc.
- the choice of a side chain-protecting group can depend on various factors, for example, type of synthesis performed, processing to which the peptide will be subjected, and the desired intermediate product or final product.
- the nature of the side chain protecting group also depends on the nature of the amino acid itself. Generally, a side chain protecting group is chosen that is not removed during deprotection of the amino groups during the solid phase synthesis ("orthogonal protection"). Therefore the amino protecting group and the side chain protecting group are preferably not the same.
- an amino acid may not require the presence of a side- chain protecting group.
- Such amino acids typically do not include a reactive oxygen, nitrogen, or other reactive moiety in the side chain.
- side chain protecting groups include acetyl (Ac), benzoyl (Bz), tert-butyl, triphenylmethyl (trityl), tetrahydropyranyl, benzyl ether (BzI) and 2,6-dichlorobenzyl (DCB), t-butoxycarbonyl(BOC), nitro, p-toluenesulfonyl (Tos), adamantyloxycarbonyl, xanthyl (Xan), benzyl, 2,6-dichlorobenzyl, methyl, ethyl and t-butyl ester, benzyloxycarbonyl (Z), 2-chlorobenzyloxycarbonyl (2-CI-Z), t- amyloxycarbonyl (Aoc), and aromatic or aliphatic urethane type protecting groups, and photolabile groups such as nitroveritryl oxycarbonyl (NVOC); and fluoride labile groups such as
- Preferred side chain protecting groups include t-Bu group for Tyr (Y), Thr(T) ; Ser (S) and Asp (D) amino acid residues; the Trt group for His (H), GIn (Q) and Asn (N) amino acid residues; and the Boc group for Lys (K) and Trp (W) amino acid residues.
- An amino-terminal protecting group includes a chemical moiety coupled to the alpha amino group of an amino acid. Typically, the amino-terminal protecting group is removed in a deprotection reaction prior to the addition of the next amino acid to be added to the growing peptide chain, but can be maintained when the peptide is cleaved from the support.
- the choice of an amino terminal protecting group can depend on various factors, for example, type of synthesis performed and the desired intermediate product or final product.
- amino-terminal protecting groups include acyl-type protecting groups, such as formyl, acrylyl (Acr), benzoyl (Bz) and acetyl(Ac); aromatic urethane-type protecting groups, such as benzyloxycarbonyl (Z) and substituted Z, such as p- chlorobenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, p-bromobenzyloxycarbonyl, p- methoxybenzyloxycarbonyl; aliphatic urethane protecting groups, such as t- butyloxycarbonyl (BOC), diisopropylmethoxycarbonyl, isopropyloxycarbonyl, ethoxycarbonyl, allyloxycarbonyl; cycloalkyl urethan-type protecting groups, such as 9-fluorenyl-methyloxycarbonyl (Fmoc), cyclopentyloxycarbonyl, adamantyloxycarbonyl
- Preferred protecting groups include 9-fluorenyl- methyloxycarbonyl (Fmoc), 2-(4-biphenylyl)-propyl (2) oxycarbonyl (Bpoc), 2- phenylpropyl (2)-oxycarbonyl (Poc) and t-butyloxycarbonyl (Boc).
- the peptide may incorporate one or more labels such as a chromophore, fluorophore, biotin or a magnetic or electron-dense entity.
- Preferred fluorophores include fluorescein, eosin, Alexa Fluor, Oregon Green, Rhodamine Green, tetramethylrhodamine, Rhodamine Red, Texas Red, coumarin and NBD.
- Solid phase chemical synthesis of DNA fragments is conveniently performed using protected nucleoside phosphoramidites.
- the 3'-hydroxyl group of an initial 5'-protected nucleoside is first covalently attached to the particle of the invention, optionally via a linker (preferably a succinic acid derivative).
- Synthesis of the oligonucleotide then proceeds by deprotection of the 5'-hydroxyl group of the attached nucleoside, followed by coupling of an incoming nucleoside-3 1 - phosphoramidite to the deprotected hydroxyl group.
- sythesis may be conducted in the 5'-3' direction. Suitable methodologies are for example disclosed in "Oligonucleotide synthesis: A practical approach" M.J. Gait, IRL Press, 1992 which is incorporated herein in its entirety.
- Residues of one or more other monomeric, oligomeric, and/or polymeric constituents optionally may also be incorporated into an oligonucleotide.
- Non-nucleotide bonds also may be present.
- the oligonucleotides of the invention may be synthesized to incorporate one or more non-nucleotide bonds. These non-nucleotide bonds may be between nucleotide residues, between a nucleotide and a non- nucleotide residue, or between two non-nucleotide residues.
- Non-nucleotide linkages include phosphorothioates, phosphonates, amides and others.
- Non-DNA base phosphoramidates may also be incorporated, and may function as linkers, labels, or functional groups (such as biotin).
- Coupling is achieved with any one of a number of coupling reagents known to those skilled in the art.
- Preferred coupling reagents are uronium salts, particularly TBTU, and diisocyanates, particularly DIC, and ETT (5-ethylthio-1f/-tetrazole).
- the resulting phosphite triester is finally oxidized to a phosphorotriester to complete the internucleotide bond.
- the steps of deprotection, coupling and oxidation are repeated until an oligonucleotide of the desired length and sequence is obtained.
- the completed oligonucleotide may optionally be cleaved from the particle. Again, the skilled person will be able to determine suitable conditions for achieving this result.
- the Chemical group conventionally used for the protection of nucleoside 5'-hydroxyls is preferably dimethoxytrityl ("DMT”), which is removable with acid.
- the oligonucleotide may incorporate one or more labels such as a chromophore, fluorophore, biotin or a magnetic or electron-dense entity.
- Preferred fluorophores include fluorescein, eosin, Alexa Fluor, Oregon Green, Rhodamine Green, tetramethylrhodamine, Rhodamine Red, Texas Red, coumarin and NBD fluorophores.
- the particles of the invention may be used as supports in the solid phase synthesis of many other classes of compound which have been demonstrated to be amenable to solid phase synthesis using conventional supports.
- Heterocycles are a preferred class of compounds.
- the particles of the invention have special utility in the preparation of libraries of chemical compounds.
- a suspension of particles is separated into three portions, each of which is then exposed to a specific reagent, A1, A2, or A3, which becomes chemically bound to the particles.
- the three suspensions of particles are then recombined within a single vessel and thoroughly mixed before being divided once again into three separate parts, each part containing a proportion of all three compound types.
- the large number of particles involved in the process ensures that statistically the numbers of each type of compound in each vessel are approximately equal.
- the three suspensions are then further exposed to the same or different reagents B1 , B2, or B3, and this results, for example in compounds A1B1 , A2B1 , and A3B1 in the first vessel; A1 B2, A2B2, and A3B2 in the second vessel; and A1 B3, A2B3 and A3B3 in the third.
- the suspensions are then remixed in a single vessel and the process repeated. In this way, a substantial number of different compounds may be produced in a relatively small number of reaction steps. At the end of the processing the identity of the compound(s) showing the desired properties may subsequently be deduced.
- Such libraries of compounds are advantageously employed in binding, inhibition, or other chemical or biochemical activities.
- a compound library affixed to a plurality of particles of the invention is brought into association with a target species.
- Particles bearing chemical compounds which bind to the target species are identified, and the nature of the chemical compound is established. Highly preferably, the nature of the chemical compound is identified by means of the tag or encoding element present on the particle.
- the target species may be a protein, an enzyme, receptor, micro organism, or a DNA or RNA fragment.
- the target species may bear a means for detection such as a radiolabel, fluorescence label, or visual label.
- Microfabrication techniques were developed to construct bars based on SU-8 photolithographic process and lift off of the patterned SU-8 bars from the substrate (Si).
- Al as a sacrificial layer
- the silicon substrates were prepared by cleaning them in fuming nitric acid for 20 minutes. 50 nm Al was coated by evaporation of pure aluminium by Al E-Gun Evaporator. An Aluminium sacrificial layer is preferred to S1813 which was also tested as particles made with the Al sacrificial layer performed better in later chemistry.
- the Al coated silicon wafers were baked at 200° C for 1 hour.
- Microposit primer was spin coated.
- SU-8 was then spin coated onto the silicon substrate coated with Al.
- a soft bake step was performed.
- the polymer was cross-linked by exposure to UV light for 18 seconds (13.6 mw cm "2 ).
- a post exposure bake of 65° C for 1 minute and 95° C for 5 minutes was performed to further cross-link the SU-8 to be resistant to solvent during processing and also to be resistant to the solvents used for later chemistry.
- the wafers were developed in polypropylene-glycol-methyl-ether-acetate (PGMEA) for 2 minutes.
- PMEA polypropylene-glycol-methyl-ether-acetate
- N-Fmoc-6-aminohexanoic acid (5.0 mg, 14 ⁇ mol) was dissolved in DMF (100 ⁇ l) and DIC (2 ⁇ l, 13 ⁇ mol) was added. The mixture was shaken for 8 min at room temperature. HOBt (2 mg, 15 ⁇ mol) was added and the mixture was shaken for 5 min at r.t. The mixture was added to Jeffamine functionalised SU8 particles (1.50 ⁇ mol based on free -NH 2 groups) suspended in DMF (300 ⁇ l) and the mixture was heated to 60 0 C for 1h. The support was washed with DMF (7 x 800 ⁇ l) followed by THF (7 x 800 ⁇ l) and dried under vacuum at room temperature for 4 h.
- HMPA HMPA (17 mg, 90 ⁇ mol) was dissolved in DMF (100 ⁇ l) and DIG (14 ⁇ l, 90 ⁇ mol) was added. The mixture was shaken for 8 min at room temperature. HOBt (12 mg, 90 ⁇ mol) was added and the mixture was shaken for 5 min at room temperature. The mixture was added to amine functionalised SU8 (30 ⁇ mol based on free -NH 2 groups) suspended in DMF (300 ⁇ l) and the mixture was shaken for 1h at room temperature. The support was washed with DMF (7 x 800 ⁇ l) and the procedure was repeated. The support was washed with DMF (7 x 800 ⁇ l) followed by THF (7 x 800 ⁇ l) and dried under vacuum at room temperature for 4 h.
- N-Fmoc-Leucine (36 mg, 100 ⁇ mol) was dissolved in DMF (50 ⁇ l) and DIC (16 ⁇ l, 100 ⁇ mol) was added. The mixture was shaken for for 8 min at room temperature.
- DMAP (1.5 mg, 10 ⁇ mol) was added and the mixture was added to HMPA SU8 (30 ⁇ mol based on -OH groups) suspended in DMF (300 ⁇ l) and the mixture was shaken for 1h at room temperature.
- the support was washed with DMF (7 x 800 ⁇ l) and the procedure was repeated twice.
- the support was washed with DMF (7 x 800 ⁇ l) followed by THF (7 x 800 ⁇ l) and dried under vacuum at room temperature for 4 h.
- N-Fmoc-amino acid 25 ⁇ mol was dissolved in DMF (50 ⁇ l) and TBTU (8 mg, 25 ⁇ mol), HOBt (0.5 mg, 4 ⁇ mol) and DIPEA (4 ⁇ l, 25 ⁇ mol) were added. The mixture was shaken for 2 min and the mixture was added to the deprotected SU8 (8 ⁇ mol based on -NH 2 groups) suspended in DMF (300 ⁇ l) and the mixture was shaken for 1h at r.t. The support was washed with DMF (3 x 800 ⁇ l) followed by THF (2 x 800 ⁇ l) and Et 2 ⁇ (3 x 800 ⁇ l). The completeness of the reaction was monitored by ninhydrin test. After a negative ninhydrin test the N-terminus Fmoc group was removed.
- the support was treated with TFA/phenol (98/2 % v/w, 25 ml/g resin) for 90 min at room temperature.
- the support was filtered and washed with TFA (3 x 1 ml).
- the combined filtrates were evaporated under vacuum and the remainder oil was titrated with Et 2 O.
- the solid that precipitated was washed with Et 2 O and dried under vacuum at room temperature for 4 h.
- SU-8 particles derivatised with succinylated base were subjected to multiple cycles of standard automated DNA synthesis using 5'-O-DMT-3'-O-phosphoramidite nucleosides. Coupling was performed with ETT as activator. After synthesis the DNA was deprotected and cleaved from the solid support by standard methods. The resulting solution was freeze dried and purified by HPLC.
- Example 8 Coupling amino-modified oligonucleotides to SU-8 microparticles.
- Amine modified SU-8 particles were treated with succinic anhydride to generate a carboxy modified surface, ⁇ '-amino modified oligonucleotides (with or without fluorescent labels) were coupled to the surface with EDC.
- Example 9 Synthesis of Leu-Enkephalin Following the procedures above amine functionalised SU-8 particles were prepared with Jeffamine and aminohexanoic acid linker and an HMPA linker. The initial amino acid Leucine was coupled on to this support followed by phenylalanine, 2 x glycine, and tyrosine. The peptide was cleaved from the resin as described. The dry solid was analysed by HPLC-MS and found to be identical to a synthetic standard.
- DNA-modified particles were suspended in an aqueous buffer containing fluorescently labelled oligonucleotide complementary to that on the particles.
- the increase in fluorescence on hybridisation was monitored using a Fluorescence Activated Cell Sorter. Incubation of the particles with a non-complementary fluorescently labelled oligonucleotide gave significantly lower fluorescence measurements by FACS.
- a peptide substrate of the HIV protease with a terminal fluorophore was synthesised on SU-8 particles. Upon treatment with the protease the particle fluorescence due to the fluorophore was lost due to peptide cleavage. The loss of fluorescence was monitored using a Fluorescence Activated Cell Sorter.
- DNA oligonucleotides were synthesised on SU-8 particles using a non-cleavable linker and deprotected in situ.
- the DNA-modified particles were then suspended in an aqueous buffer containing fluorescently labelled oligonucleotide complementary to that on the particles.
- the increase in fluorescence on hybridisation was monitored using a Fluorescence Activated Cell Sorter. Incubation of the particles with a non- complementary fluorescently labelled oligonucleotide gave significantly lower fluorescence measurements by FACS.
Landscapes
- Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Nanotechnology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Materials Engineering (AREA)
- Crystallography & Structural Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0426809.0 | 2004-12-07 | ||
GB0426809A GB0426809D0 (en) | 2004-12-07 | 2004-12-07 | Nano-optical diffraction bar-code tagging for biological and chemical applications |
GB0507181A GB2421076A (en) | 2004-12-07 | 2005-04-08 | Identifiable particles and uses thereof |
GB0507181.6 | 2005-04-08 | ||
GB0518478.3 | 2005-09-09 | ||
GB0518478A GB2422686A (en) | 2004-12-07 | 2005-09-09 | Preparation of solid support particles for chemical reactions |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006061600A1 true WO2006061600A1 (fr) | 2006-06-15 |
Family
ID=35773728
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2005/004681 WO2006061600A1 (fr) | 2004-12-07 | 2005-12-07 | Particules destinees a servir de supports solides, et leur procede de preparation |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006061600A1 (fr) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997006468A2 (fr) * | 1995-07-28 | 1997-02-20 | Ely Michael Rabani | Formation, reproduction, fabrication d'un motif et dispositifs ainsi obtenus |
GB2306484A (en) * | 1995-10-26 | 1997-05-07 | Univ Hertfordshire | Solid support particle marked with a machine-readable code for use in Combinatorial Chemistry Techniques |
WO2002059603A2 (fr) * | 2001-01-26 | 2002-08-01 | Aviva Biosciences Corporation | Microdispositifs contenant des motifs de codage reconnaissables par photo-analyse et procedes d'utilisation et de production correspondants |
US20030129654A1 (en) * | 1999-04-15 | 2003-07-10 | Ilya Ravkin | Coded particles for multiplexed analysis of biological samples |
US20030153092A1 (en) * | 2000-04-19 | 2003-08-14 | Skinner Nigel Guy | Method of fabricating coded particles |
GB2393785A (en) * | 2002-10-03 | 2004-04-07 | Toshiba Res Europ Ltd | Method of making a free standing structure |
WO2004066210A1 (fr) * | 2003-01-22 | 2004-08-05 | Cyvera Corporation | Micro-reseau utilisant une bille/puce aleatoire hybride |
-
2005
- 2005-12-07 WO PCT/GB2005/004681 patent/WO2006061600A1/fr active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997006468A2 (fr) * | 1995-07-28 | 1997-02-20 | Ely Michael Rabani | Formation, reproduction, fabrication d'un motif et dispositifs ainsi obtenus |
GB2306484A (en) * | 1995-10-26 | 1997-05-07 | Univ Hertfordshire | Solid support particle marked with a machine-readable code for use in Combinatorial Chemistry Techniques |
US20030129654A1 (en) * | 1999-04-15 | 2003-07-10 | Ilya Ravkin | Coded particles for multiplexed analysis of biological samples |
US20030153092A1 (en) * | 2000-04-19 | 2003-08-14 | Skinner Nigel Guy | Method of fabricating coded particles |
WO2002059603A2 (fr) * | 2001-01-26 | 2002-08-01 | Aviva Biosciences Corporation | Microdispositifs contenant des motifs de codage reconnaissables par photo-analyse et procedes d'utilisation et de production correspondants |
GB2393785A (en) * | 2002-10-03 | 2004-04-07 | Toshiba Res Europ Ltd | Method of making a free standing structure |
WO2004066210A1 (fr) * | 2003-01-22 | 2004-08-05 | Cyvera Corporation | Micro-reseau utilisant une bille/puce aleatoire hybride |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2729739C (fr) | Jeux ordonnes d'echantillons composites utilisant des microspheres | |
EP2054711B1 (fr) | Procédé de fabrication de microréseaux | |
AU771458B2 (en) | Automated information processing in randomly ordered arrays | |
EP1432989B1 (fr) | Jeux d'echantillons ordonnes de facon aleatoire et procedes de fabrication et d'utilisation | |
US7695910B2 (en) | Method for manufacturing hydrogel biochip by using star-like polyethylene glycol derivative having epoxy group | |
DE69132843T2 (de) | Identifizierung von Nukleinsäuren in Proben | |
US7338768B1 (en) | Carrier-reporter bead assemblies | |
CN104884957B (zh) | 微阵列基板上的生化分子的分离方法 | |
JP2002535013A (ja) | 複製可能なプローブアレー | |
US20030059804A1 (en) | Method for producing micro-carrier and test method by using said micro-carrier | |
US20160222441A1 (en) | Materials and Methods Relating to Nano-Tags and Nano-Barcodes | |
WO2004067759A2 (fr) | Replication de jeux ordonnes d'echantillons d'acides nucleiques | |
WO2003069333A1 (fr) | Traitement des donnees automatique dans des matrices organisees de façon aleatoire | |
JP2002519637A (ja) | 微小球を有するアレイセンサーのデコード | |
JP7375998B2 (ja) | バイオチップ、その調製方法及び使用 | |
US6849397B2 (en) | Label-free detection of nucleic acids via surface plasmon resonance | |
Mandal et al. | Cytophobic surface modification of microfluidic arrays for in situ parallel peptide synthesis and cell adhesion assays | |
WO2006061600A1 (fr) | Particules destinees a servir de supports solides, et leur procede de preparation | |
WO2006113037A1 (fr) | Méthode de photographie d'un ensemble de microsphères | |
US10376858B2 (en) | Ultra high-density oligomer arrays and method of production thereof | |
GB2422686A (en) | Preparation of solid support particles for chemical reactions | |
Wang et al. | Small molecule microarrays: Applications using specially tagged chemical libraries | |
GB2421076A (en) | Identifiable particles and uses thereof | |
Popov | Process Development for Manufacturing Stochastic Peptide Microarrays | |
Palfreyman et al. | Fabrication of Magnetic Barcoded Microcarriers for Biomolecular Labeling: SU‐8 Encapsulated Magnetic Tags |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 05813921 Country of ref document: EP Kind code of ref document: A1 |